We've found
6,735
archived clinical trials in
Psoriasis
We've found
6,735
archived clinical trials in
Psoriasis
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Updated: 12/31/1969
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Updated: 12/31/1969
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Status: Enrolling
Updated: 12/31/1969
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Updated: 12/31/1969
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
Updated: 12/31/1969
Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
Status: Enrolling
Updated: 12/31/1969
Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
Updated: 12/31/1969
Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Potential Research Study Participant Registry
Updated: 12/31/1969
Potential Research Study Participant Registry
Status: Enrolling
Updated: 12/31/1969
Potential Research Study Participant Registry
Updated: 12/31/1969
Potential Research Study Participant Registry
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Chronic Plaque Psoriasis (Ps) Registry
Updated: 12/31/1969
A 10-Year, Post-marketing, Observational Study to Assess Long Term Safety of HUMIRA® (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (PS)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials